Skip to main content

Want a detailed portfolio tracker?

TPST
NASDAQ
$0.95

Tempest Therapeutics Inc (TPST)

Tempest Therapeutics Inc., a clinical-stage oncology company, is dedicated to the development of small molecules that combine targeted and immune-mediated mechanisms with the potential to treat various tumors. The company is headquartered in South San Francisco, California.
Website: https://www.tempesttx.com
Sector:
Healthcare
Industry:
Biotechnology
Target: $11 (+1054.98%)

Market Cap

$15M

Price Chart

Valuation
Market Cap$15M
P/B19.20
Profitability
EBITDA-$43M
EPS-$5.31
Growth & Risk
FCF 5Y CAGR+0.25%
Sharpe Ratio-1.33